Eric Rhodes

ERS Genomics has appointed Eric Rhodes as CEO. He succeeds founder Shaun Foy who has been appointed chairman of the company's board of directors. Rhodes joins ERS from Horizon Discovery where he was responsible for commercializing Horizon's genome editing technologies and overseeing research and development. Before his time at Horizon, he held various positions focused on gene editing technologies, including director of business development at Sigma-Aldrich and vice president of business development and alliance management at Sangamo Biosciences.